PharmaTher Holdings Ltd. (PHRM.CN)
CAD 0.23
(2.22%)
CAD 0.23
(2.22%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.13 Million CAD | 63.96% |
| 2022 | -5.91 Million CAD | 35.34% |
| 2021 | -9.15 Million CAD | -229.54% |
| 2020 | -2.77 Million CAD | -615.3% |
| 2019 | -388.38 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.8 Million CAD | 15.55% |
| 2023 Q1 | -4.26 Million CAD | 27.95% |
| 2023 Q3 | -2.42 Million CAD | 22.94% |
| 2023 Q4 | -2.13 Million CAD | 12.18% |
| 2023 Q2 | -3.15 Million CAD | 26.1% |
| 2022 FY | -5.91 Million CAD | 35.34% |
| 2022 Q2 | -7.14 Million CAD | 7.75% |
| 2022 Q1 | -7.74 Million CAD | 15.38% |
| 2022 Q4 | -5.91 Million CAD | 10.77% |
| 2022 Q3 | -6.63 Million CAD | 7.17% |
| 2021 Q3 | -10.16 Million CAD | 9.85% |
| 2021 Q4 | -9.15 Million CAD | 9.94% |
| 2021 Q2 | -11.27 Million CAD | -363.52% |
| 2021 Q1 | -2.43 Million CAD | 12.43% |
| 2021 FY | -9.15 Million CAD | -229.54% |
| 2020 Q4 | -2.77 Million CAD | 23.67% |
| 2020 FY | -2.77 Million CAD | -615.3% |
| 2020 Q3 | -3.63 Million CAD | -264.95% |
| 2020 Q1 | -1.57 Million CAD | 0.0% |
| 2020 Q2 | -997.23 Thousand CAD | 36.8% |
| 2019 FY | -388.38 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -125.08 Thousand CAD | -1605.425% |
| Asep Medical Holdings Inc | -44.72 Thousand CAD | -4670.088% |
| BetterLife Pharma Inc. | 207.85 Thousand CAD | 1126.332% |
| BioVaxys Technology Corp. | -977.00 CAD | -218245.036% |
| ChitogenX Inc. | 3.84 Million CAD | 155.553% |
| Rapid Dose Therapeutics Corp. | 2.29 Million CAD | 193.048% |
| Defence Therapeutics Inc. | 1.68 Million CAD | 226.234% |
| Entheon Biomedical Corp. | -344.63 Thousand CAD | -518.986% |
| Gemina Laboratories Ltd. | 284.33 Thousand CAD | 850.25% |
| Glow Lifetech Corp. | 116.15 Thousand CAD | 1936.617% |
| Lexston Life Sciences Corp. | -390.4 Thousand CAD | -446.415% |
| Pharmala Biotech Holdings Inc. | 58.49 Thousand CAD | 3746.86% |
| Doseology Sciences Inc. | -1.06 Million CAD | -101.206% |
| MYND Life Sciences Inc. | 2.99 Million CAD | 171.114% |
| Nova Mentis Life Science Corp. | -8088.00 CAD | -26275.26% |
| PreveCeutical Medical Inc. | 3.83 Million CAD | 155.658% |
| Telescope Innovations Corp. | -719.49 Thousand CAD | -196.491% |